The Effectiveness of Idazoxan in Treating TRD

Sheba Medical Center

Overview

Assessing the effectiveness of Idazoxan as a treatment for depressive patients who did not respond to treatment with SSRI

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Major Depressive Disorder

Interventions

IdazoxanDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * MDD patients * Did not respond to at least one treatment of 4-6 weeks of SSRI in adequate dose * In or out patients Exclusion Criteria: * Psychotic symptoms

Locations (1)

Chaim Sheba Medical Center

Ramat Gan, Israel

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.